We estimate the effects of the ACA's Medicaid expansion on health outcomes with a difference-in-differences approach, using restricted geotagged NHANES data from 2007 to 2014. Our results show that the partial Medicaid expansion in 2014 is significantly associated with a decrease of 8.465 mg / dL (4.3%) in total cholesterol and decrease of 5.569 mmHg in systolic blood pressure (4.7%). These are both likely the result of an increase in the use of cholesterol lowering medications, which can affect both of these measures, as there is no corresponding increase in the use of blood pressure medication. Contrastingly, we find no statistically significant effects for diabetes prescriptions or measures.
I. Introduction
While Medicaid before 2014 provided health coverage to millions of Americans, many low-income adults were largely ineligible. These individuals could not afford to manage chronic conditions due to a lack of health insurance and the resulting unaffordable out-of-pocket medical costs, effectively reducing access to health care services. The Affordable Care Act was intended to close this coverage gap by expanding Medicaid to adults with income of or below 138% of the federal poverty level, making most low-income adults largely eligible.
Prior to 2014 ACA Medicaid expansion, several papers studied the effects of earlier expansions. The 2008 Oregon expansion of traditional Medicaid showed that Medicaid eligibility leads to greater health care utilization, lower out-of-pocket medical expenditures, fewer medical bills, and better self-reported health (Finkelstein et al. 2012 ); yet it seemed to have no statistically significant effect on hypertension, high cholesterol levels, or high hemoglobin levels (Baicker et al. 2013) . Better adult health conditions are also found to be associated with mother's prenatal coverage under Medicaid in their early life . Finally, the prior Medicaid expansions also reduced the Supplemental Security Income (SSI) participation (Burns and Dague 2016) , as previously one needed to get onto SSI to get Medicaid.
Despite the intention of the Affordable Care Act, the Supreme Court in 2012 permitted individual states to opt not to expand Medicaid and to decline substantial federal funding. This partial expansion 1 has generated an abundance of research to evaluate the impacts of the Medicaid expansion in numerous aspects. Relative to non-expansion states, expansion states have increases in health insurance coverage for low-income adults (Black and Cohen 2015; Blumberg et al. 2016 ) and decrease in the uninsured rate (Benitez et al. 2016; ). However, multiple other papers find minimal effects on labor supply, measured by employment status, labor force participation, or hours worked (Kaestner et al. 2015; Hamersma and Unel 2015; Leung and Mas 2016; Bradley et al. 2016; Gooptu et al. 2016) . There is at least some evidence, though, for a reduction in hours worked for people who working with lower educational attainment , and a trade-off between full-time and part-time (Aslim 2016) . Finally, consistent with the work from the Oregon expansion (Finkelstein et al. 2012) , the ACA Medicaid expansion also improves multiple economic outcomes. This includes significant reductions in the number of unpaid bills and the amount of debt , increased personal credit score and decreased the probability of bankruptcy (Caswell 2016) , and a reduction in federal disability program participation (Chatterji and Li 2016) .
On the hospital side, the Medicaid expansion has caused a significant increase in
Medicaid admissions, as well as a significant decrease in admissions covered by other commercial insurance. (Hempstead and Cantor 2016) . Uncompensated care costs have also decreased (Blavin and Holahan 2016) , while Medicaid discharges and hospital revenues have been increased (Nikpay 2016) . At the individual level, many papers point to improvements of access to health care, such as physician visit, certain dental visit, overnight hospital stays, and breast exam Simon et al. 2016; , and utilization of health services (Decker 2016) . However, a few papers did not find significant effects on health care access and utilization (Shartzer et al. 2015; ). To our knowledge, however, only one paper has examined health outcomes and found an increase in diagnoses of diabetes by 5.2 percentage points and diagnoses of high cholesterol by 5.7 percentage points .
The primary reason for this lack of research on health outcomes is data limitations. Our paper is the first to use professionally gathered actual health data to study the impact of the Medicaid expansion. The National Health and Nutrition Examination Survey (NHANES) microdata contain the results of a health examination, as well as the interview questions found in other surveys. While this data has not previously been used to study the ACA Medicaid Expansion, one paper has used this data cross-sectionally to examine the correlation between health insurance and the health outcomes using NHANES 1999-2012, showing that health insurance coverage was associated with significant lower Hemoglobin A1c, total cholesterol and systolic blood pressure (Hogan et al. 2015) .
In our paper, we seek to be the first to we examine the impacts of the ACA Medicaid expansion in 2014 on direct health measures, including both the diagnoses and measures of diabetes, high blood pressure, and high cholesterol. We will exploit the effects of the statevariation resulting from the partial Medicaid expansion, using a difference-in-differences model. Our paper will improve our understanding of how public policy decisions regarding health coverage impact health outcomes. As many states consider expanding, knowing the benefits and costs to their citizens would allow policy makers and voters to make more informed decisions.
II. Data
As mentioned above, the primary data used in this analysis come from a restricted version of the National Health and Nutrition Examination Survey (NHANES) for the years 1999-2014. The NHANES data is designed to directly and objectively assess the health and nutrition conditions of American adults and children. This survey is a unique data set with both interviews and physical examinations, which provides both professional and self-reported diagnostic health information of individuals in our analysis, as well as demographic and geographic information.
We limit the sample to non-disabled adult age 19 to 64 with high school education or less.
This is preferable to defining the sample by income, the Medicaid expansion is targeted at people with income of or less than 138% of Federal Poverty Level (FPL) and so income is endogenous.
Educational attainment, on the other hand, is strongly correlated with income but not directly related to Medicaid eligible and so provides a reasonable "intent to treat" subsample. Such sample stratification is used in Kaestner et al. (2015) . In addition to this subsample, we also include a separate sample with college graduates as a comparison placebo group.
As described above, the NHANES collects information on both objective and selfreported health outcomes. Objective health outcomes come from the NHANES examination and laboratory tests, while self-reported health information are from individual interview and questionnaire. In our analysis, we focus on three health outcomes: total cholesterol, systolic blood pressure, and hemoglobin A1c, as per Hogan et al. (2015) 's work with the NHANES on the correlation between Medicaid and health. All of these also have the benefit of not needing to be measured while fasting (Sidhu et al. 2012) , allowing us to use the larger examination subsample as opposed to the smaller fasting subsample.
In addition to these examination variables, there are also variables for self-reported information from the interviews. This includes three related variables for each condition. One is whether a physician has diagnosed the individual with the condition associated with that variable (i.e., hypercholesterolemia, hypertension, and diabetes, respectively). Another is whether a physician has ever told the individual to take medication for that condition. Finally, the third is whether the individual is currently taking the prescribed medicine for that condition.
Additionally, the data set also contains variables on a variety of demographic information on each individuals, as well information on health insurance.
We supplement the NHANES data with public data from BLS's Local Area Unemployment Statistics). This allows us to control for the seasonally unadjusted unemployment rate at the county-month level, as unemployment affects both Medicaid eligibility (through income) and health outcomes (e.g., Ruhm 2000; Cutler et al. 2016 ).
Finally, the restricted version of the NHANES that at we used for this project contains several non-public variables, including the dates of the examination and interview, the state and county of residence of the respondent, and the annual survey weight (as opposed to the public biennial ones). This allows us to match each observation to whether he or she lived in a treated or control state and whether the expansion was in effect (as described below), and also match in the county-level unemployment rate.
III. Methodology
Our primary source of variation in this paper is whether a surveyed individual lives in a state that was substantially affected by the Medicaid expansion. We use a difference-indifference (DID) research design, comparing changes in outcomes in the group of treated states to the same changes in the control states. Following Kaestner et al. (2015) 's classification strategy, we group states by expansion status and the implementation of expansions prior to 2014 which is similar to ACA is another piece of information that included in classification criteria.
Such classification is more reasonable since early expansion experience would influence the differences in the impacts of ACA before and after the expansion. The treated states fall into one of two categories:
• Treated states that expanded Medicaid in 2014 and had a partial or limited prior expansion similar to the ACA: AZ, CA, CO, CT, HI, IA, IL, MD, MN, NJ, OR RI, and WA.
• • Non-Medicaid expansion states that had no prior expanding experience: AL, AK, FL, GA, ID, KS, LA, MS, MO, MT, NE, NC, OK, PA, SC, SD, TX, UT, VA, and WY.
• Non-Medicaid expansion states that had limited/partial prior expanding experience: IN, ME, TN, and WI.
• Medicaid expansion states that had full/comprehensive prior expanding experience similar to ACA: DE, DC, MA, NY, and VT.
With the above classification, we estimate the effect of ACA Medicaid expansion on health outcomes using the following regression models. In the following equations, i is for an individual in the survey, c for the county that individual lives in, s for the state that individual lives in, and t for the time of the interview.
y are the outcomes of interest, including, cholesterol, blood pressure, and diabetes. X is a vector individual level demographic controls, including age, gender, racial dummy indicators, family income poverty ratio, marital status, family size, household size, citizenship status, and pregnancy status. It also includes the county-time-level unemployment rate control. time is a vector of year and month fixed effects (to control for national level differences by year and also for seasonality), and geography a vector of state fixed effects (to control for time invariant level differences by geography). σ is the primary coefficient of interest.
Implemented will equal one if the year (of interview or examination, depending on the outcome) is 2014 and zero otherwise. The sample will be limited to those age 19-64 (to avoid confounding the results with programs for children or the elderly), and educational attainment of a high school diploma or less (per Kaestner et al. 2015 and Hu et al. 2016 ). The years [2007] [2008] [2009] [2010] [2011] [2012] [2013] will be used as control years to be compared to 2014. The regression is weighted using the restricted annual interview or examination weight corresponding to source of the outcome variable.
We also include three sets of placebo analysis. First of all, each observation is missing data for a subset of the variables of interest. Limiting the data to observations that do not have missing values for a bare minimum of our variables reduces the sample size enormous.
Nevertheless, we select consistent sample with key health and demographic variables, and run the same DID regression.
Secondly, there is a concern that other trends may be contemporaneous with the Medicaid expansion and be correlated with which states did and did not expand. Per Slusky (2015) , this analysis also includes placebo regressions using data back to 1999 with each 7 consequence years of "comparison" data compared to the subsequent "treatment" year (e.g., 1999-2005 vs. 2006 ).
Finally, we will also repeat the primary analysis on individuals who are college graduates as an additional placebo test, with the hypothesis that they are minimally affected by the Medicaid expansion. The regression results with college graduates will be included in the main results tables in the following section.
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IV. Results
Descriptive statistics are presented in Tables 1 and 2 . Table 1 shows the counts of observations in our analytical sample for treated and control states before and after the Medicaid expansion took effect. Table 4 show analogous results for blood pressure. Regressions are weighted using the restricted annual weights for either the interview or exam sample. Individual level demographic controls include age, gender, race, family income poverty ratio, marital status, family size, household size, citizenship status, and pregnancy status. Year, month, and state fixed effects are included, as is the seasonally unadjusted monthly county unemployment rate. *** p<0.01, ** p<0.05, * p<0.1
While the first three columns of the high school sample and all of the columns of the college sample show statistically insignificant results, the treated individuals in the high school sample have systolic blood pressure that is 5.569 mmHg lower, which on a pre-2014 treatment state mean of 118.7 mmHg is decrease of 4.7%.
Finally, Table 5 shows the results for diabetes. Notes: HS = High school diploma or less. COL = College Graduate. Robust standard errors clustered at the state level are in parentheses. Regressions are weighted using the restricted annual weights for either the interview or exam sample. Individual level demographic controls include age, gender, race, family income poverty ratio, marital status, family size, household size, citizenship status, and pregnancy status. Year, month, and state fixed effects are included, as is the seasonally unadjusted monthly county unemployment rate. *** p<0.01, ** p<0.05, * p<0.1
Here, none of the results are more than marginally statistically significant, nor is there even any kind of consistent story one can tell about the point estimates.
V. Robustness Checks
We run two robustness checks for our main DID regressions with the lower educational attainment subsample. First, we look at a subset of the subsample that has non-missing values for our four key NHANES outcome variables: told to take medication for cholesterol and blood pressure, and total cholesterol and systolic blood pressure. We limit our non-missing restriction to these variables to maintain as much statistical power as possible. Appendix Table 1 shows the results of these four regressions, which are reassuringly largely consistent with the main results from above: more cholesterol medication and lower cholesterol and systolic blood pressure.
Additionally, Appendix Tables 2-4 contain the results of back-in-time placebo regressions, per Slusky (2015). Here we use the same classification of treated and control states as above but we shift the analysis window back in time, with a different pre-2014 year serving as the "treated" year and the previous 7 years as the "control" years. We can do this back to 1999
as that is as far back as there is consistent NHANES data. We use the demographic controls and outcomes for the actual individual observations from those time years and also use the unemployment rates that correspond to those years.
In these tables, we see 1) statistically insignificant placebo coefficients where our main coefficient is statistically significant, 2) statistically significant placebo coefficients where our main coefficient is statistically insignificant, or 3) statistically significant placebo coefficients where our main coefficient is also statistically significant but of the opposite sign. None of these is a major concern for the robustness of our results: the first is obvious, the second is where we are already not rejecting the null hypothesis, and the third would suggest confounding results that are biasing ours toward zero, not away from it.
VI. Discussion
The results from the tables above are that the Medicaid expansion increased individual's propensity to be cholesterol lowering perscriptions, which had the dual effect of lowering total cholesterol and also lowering blood pressure. There was no statistically significant increase in the share of individuals diagnosed with high blood pressure or diabetes nor any changes in medication for those conditions.
At first glance, though, the cholesterol results are somewhat puzzling given a strong increase in the share of individuals taking medicine but a statistically insignificant increase in the share of individuals diagnosed with high cholesterol. However, there is medical literature suggesting that individuals are often prescribed cholesterol lowering medication despite having only borderline high cholesterol or having other general symptom of metabolic disease (Grundy 2014 ).
Additionally, the blood pressure results appear puzzling as there is a drop in blood pressure despite no change in medication. One potential explanation is that a common side effect of cholesterol lowering medication is lowered blood pressure (Golomb et al. 2008) . So it is plausible that the substantial increase in cholesterol lower prescriptions is also lowering blood pressure.
While our results are the first to use direct examination data as opposed to interview data, the interview results themselves are statistically weaker than those of Wherry and Miller (2016) who find using NHIS data that the Medicaid expansion did increase the diagnosis of diabetes.
However, the NHIS data is a substantially larger sample size, and so would have far more statistical power than the few hundred observations that we have in the treated states in 2014.
VII. Conclusion
In this paper, we examine whether the ACA Medicaid expansion in 2014 improve health using NHANES data for objectively collected and self-reported health measures, 2007-2014. We limit the sample to be non-disabled adults age 19 to 64 with high school education or less. With the concern endogeneity of income to Medicaid, we use education to stratify the sample.
Estimates of Medicaid expansion on health outcomes shows that the ACA Medicaid expansion is associated with a 7 percentage point increase in cholesterol lowering medication usage, a 
